Los Angeles Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Arrowhead to Buy a Cancer Treatment Portfolio from Novartis

Pasadena biotechnology company Arrowhead Research Corp. announced today that it had struck a deal to acquire the RNAi research and development portfolio of drug maker Novartis in a deal valued at about $35 million.

Lizada Capital to Become Largest Medbox Shareholder

Cannabis investment firm Lizada Capital signed a $15 million deal Wednesday that will make it Medbox’s largest shareholder.

CEO Announcement Boosts Staar Surgical Shares

Caren Mason, who was elected to implantable lens maker Staar Surgical Co.’s board last June, was named Tuesday as chief executive, replacing Barry Caldwell who retired March 1.

Herbalife Chief’s Compensation Slashed

If Herbalife Ltd. Chief Executive Michael Johnson sounded upbeat on the company’s recent earnings call, it likely had nothing to do with his 2014 compensation.

Herbalife's Fourth-Quarter Earnings Prove Disappointing

Herbalife Ltd., the embattled downtown Los Angeles nutritional supplement company, reported its fourth quarter earnings, with some disappointing results, after markets closed Thursday.

It’s Official: Attorney General Approves Sale of Daughters of Charity Health System to Prime Healthcare Services

California Attorney General Kamala Harris handed down a hotly anticipated verdict on Friday.

Reports: Anthem Hack Affected Past Customers

The data breach at Anthem Inc. was broader than initially thought and could affect customers as far back as 2004, according to media reports on Thursday.

Two L.A. Hospitals Fined by CDPH

Two Los Angeles-area hospitals were among 10 fined by the California Department of Public Health today after investigations found the facilities had not complied with licensing requirements. And their actions caused, or were likely to cause, serious injury or death to patients.

Anthem Officials Investigate How California Members Fared in Hack

Officials with Anthem Blue Cross Inc. in Thousand Oaks were still determining Thursday how many of its California members may have had personal information compromised by a huge security breach at its parent company.

Decision on Fate of Daughters of Charity Sale Delayed

The contentious fight over the fate of six Daughters of Charity hospitals, including two in Los Angeles County, has been extended by another two weeks. The deadline by which Attorney General Kamala Harris must review and approve the sale of Daughters’ medical centers to Prime Healthcare Services has been pushed to Feb. 20.

Amgen Beats Estimates

Amgen Inc. reported fourth-quarter and full-year financial results on Tuesday that topped analysts’ estimates as the company reaped the benefits of previously announced layoffs, a tax credit and strong drug sales.

Health One to Stop Producing Unapproved Supplements and Drugs

Health One Pharmaceuticals Inc., a City of Industry manufacturer of dietary supplements and drugs, has been shut down as part of a consent decree reached with the Department of Justice.

Soon-Shiong’s NantWorks Targeted by Former Employees Alleging Fraud

Two former employees of billionaire Patrick Soon-Shiong’s health care technology company NantHealth have alleged the firm and its Culver City holding company NantWorks had engaged in a multitude of fraudulent activities.

NantWorks Subsidiary Inks Licensing Deal With Amgen

NantWorks, billionaire Patrick Soon-Shiong’s Culver City holding company, has launched an immuno-oncology company and inked a deal with Amgen Inc. of Thousand Oaks to license an oncology antibody.

Arrowhead Falls After FDA Alters Drug Trial

Arrowhead Research Corp. saw its stock plummet 24 percent Monday after the Food and Drug Administration placed a partial clinical hold on one of its drugs.